Literature DB >> 26228998

Bolus intravenous 0.9% saline, but not 4% albumin or 5% glucose, causes interstitial pulmonary edema in healthy subjects.

Shailesh Bihari1, Ubbo F Wiersema2, David Schembri3, Carmine G De Pasquale4, Dani-Louise Dixon5, Shivesh Prakash2, Mark D Lawrence6, Jeffrey J Bowden3, Andrew D Bersten5.   

Abstract

Rapid intravenous (iv) infusion of 0.9% saline alters respiratory mechanics in healthy subjects. However, the relative cardiovascular and respiratory effects of bolus iv crystalloid vs. colloid are unknown. Six healthy male volunteers were given 30 ml/kg iv 0.9% saline, 4% albumin, and 5% glucose at a rate of 100 ml/min on 3 separate days in a double-blinded, randomized crossover study. Impulse oscillometry, spirometry, lung volumes, diffusing capacity (DLCO), and blood samples were measured before and after fluid administration. Lung ultrasound B-line score (indicating interstitial pulmonary edema) and Doppler echocardiography indices of cardiac preload were measured before, midway, immediately after, and 1 h after fluid administration. Infusion of 0.9% saline increased small airway resistance at 5 Hz (P = 0.04) and lung ultrasound B-line score (P = 0.01) without changes in Doppler echocardiography measures of preload. In contrast, 4% albumin increased DLCO, decreased lung volumes, and increased the Doppler echocardiography mitral E velocity (P = 0.001) and E-to-lateral/septal e' ratio, estimated blood volume, and N-terminal pro B-type natriuretic peptide (P = 0.01) but not lung ultrasound B-line score, consistent with increased pulmonary blood volume without interstitial pulmonary edema. There were no significant changes with 5% glucose. Plasma angiopoietin-2 concentration increased only after 0.9% saline (P = 0.001), suggesting an inflammatory mechanism associated with edema formation. In healthy subjects, 0.9% saline and 4% albumin have differential pulmonary effects not attributable to passive fluid filtration. This may reflect either different effects of these fluids on active signaling in the pulmonary circulation or a protective effect of albumin.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  0.9% saline; 4% albumin; 5% glucose; cardiac output; pulmonary edema; ultrasound

Mesh:

Substances:

Year:  2015        PMID: 26228998     DOI: 10.1152/japplphysiol.00356.2015

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  6 in total

1.  Does Intravenous Infusion Influence Diagnostic Ultrasound-Induced Pulmonary Capillary Hemorrhage?

Authors:  Douglas L Miller; Zhihong Dong; Chunyan Dou; Krishnan Raghavendran
Journal:  J Ultrasound Med       Date:  2018-02-09       Impact factor: 2.153

Review 2.  0.9% NaCl (Normal Saline) - Perhaps not so normal after all?

Authors:  Neil Blumberg; Jill M Cholette; Anthony P Pietropaoli; Richard Phipps; Sherry L Spinelli; Michael P Eaton; Suzie A Noronha; Jerard Seghatchian; Joanna M Heal; Majed A Refaai
Journal:  Transfus Apher Sci       Date:  2018-02-21       Impact factor: 1.764

3.  Fluid-induced lung injury-role of TRPV4 channels.

Authors:  Shailesh Bihari; Dani-Louise Dixon; Mark D Lawrence; Dylan De Bellis; Claudine S Bonder; David P Dimasi; Andrew D Bersten
Journal:  Pflugers Arch       Date:  2017-04-29       Impact factor: 3.657

Review 4.  Fluid Bolus Therapy in Pediatric Sepsis: Current Knowledge and Future Direction.

Authors:  Ben Gelbart
Journal:  Front Pediatr       Date:  2018-10-25       Impact factor: 3.418

5.  Assessment of fluid unresponsiveness guided by lung ultrasound in abdominal surgery: a prospective cohort study.

Authors:  Stéphane Bar; Céline Yee; Daniel Lichtenstein; Magali Sellier; Florent Leviel; Osama Abou Arab; Julien Marc; Matthieu Miclo; Hervé Dupont; Emmanuel Lorne
Journal:  Sci Rep       Date:  2022-01-25       Impact factor: 4.379

6.  Clinical iron deficiency disturbs normal human responses to hypoxia.

Authors:  Matthew C Frise; Hung-Yuan Cheng; Annabel H Nickol; M Kate Curtis; Karen A Pollard; David J Roberts; Peter J Ratcliffe; Keith L Dorrington; Peter A Robbins
Journal:  J Clin Invest       Date:  2016-05-03       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.